Latest news
The Mechanism of Action of Evorpacept in Breast Cancer - OncLiveOncLive · Fri, 07 Aug 2026 11:00:32 GMTALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - manilatimes.netmanilatimes.net · Thu, 06 Aug 2026 12:22:02 GMTDr Hurvitz on Evorpacept Plus Zanidatamab in Pretreated HER2+ Metastatic Breast Cancer - OncLiveOncLive · Fri, 31 Jul 2026 19:49:53 GMT